Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life‑changing therapies ...
I'm someone who loves studying and having discussions in class with my classmates and teachers. I'm sure we all have our favorite teachers from school (my English teacher was the best!)—but then, ...
2h
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...
Can Ben Lamm save the planet? He thinks so. Short, stocky and unassuming with a puckish sense of humor, the shaggy-haired Dallas-based entrepreneur seems more like the brainiac in the back of class ...
TRYNGOLZA® generated $108 million in net product sales in 2025, the first year of launch –- Olezarsen sHTG launch preparations on track, sNDA submitted -- Exceeded 2025 financial guidance, 2026 ...
Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinica ...
MYQORZO® Approved for Adults with Symptomatic Obstructive HCM in U.S., China and Europe; U.S. Launch Underway with First Prescriptions Dispensed ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results